| P2093 | author name string | S Sujatha | |
| | P Ravindra Babu | |
| | K Kishore Kumar | |
| | K Gnananath | |
| | Leena Priyanka | |
| P2860 | cites work | Effect of genistein on the pharmacokinetics of paclitaxel administered orally or intravenously in rats | Q79699161 |
| | Altered pharmacokinetics of paclitaxel by the concomitant use of morin in rats | Q79809319 |
| | Effects of morin on the pharmacokinetics of etoposide in rats | Q79812011 |
| | Co-administration of cyclosporin enables oral therapy with paclitaxel | Q95807142 |
| | Inhibition of human CYP3A4 activity by grapefruit flavonoids, furanocoumarins and related compounds | Q28209705 |
| | Inhibitory effects of polyphenols on human cytochrome P450 3A4 and 2C9 activity | Q28263349 |
| | Anti-asthmatic action of quercetin and rutin in conscious guinea-pigs challenged with aerosolized ovalbumin | Q28267509 |
| | Flavonoids-potent and versatile biologically active compounds interacting with cytochromes P450. | Q34501881 |
| | Emerging significance of flavonoids as P-glycoprotein inhibitors in cancer chemotherapy. | Q34983061 |
| | Limited oral bioavailability and active epithelial excretion of paclitaxel (Taxol) caused by P-glycoprotein in the intestine | Q36031211 |
| | Flavonoids: a class of modulators with bifunctional interactions at vicinal ATP- and steroid-binding sites on mouse P-glycoprotein | Q36277561 |
| | Enhanced oral bioavailability of paclitaxel in mice treated with the P-glycoprotein blocker SDZ PSC 833. | Q36431370 |
| | Hypersensitivity reactions to antineoplastic agents: an overview | Q37431466 |
| | Modulation of activator protein-1 (AP-1) and MAPK pathway by flavonoids in human prostate cancer PC3 cells. | Q40233428 |
| | Apigenin inhibits VEGF and HIF-1 expression via PI3K/AKT/p70S6K1 and HDM2/p53 pathways. | Q40450886 |
| | Neuroprotective effects of flavones on hydrogen peroxide-induced apoptosis in SH-SY5Y neuroblostoma cells | Q40567527 |
| | Effect of flavonoids on MRP1-mediated transport in Panc-1 cells | Q40676739 |
| | Clinical toxicities encountered with paclitaxel (Taxol). | Q40711497 |
| | Oral chemotherapy: rationale and future directions | Q40851033 |
| | Modulation of adriamycin accumulation and efflux by flavonoids in HCT-15 colon cells. Activation of P-glycoprotein as a putative mechanism | Q41436320 |
| | Apigenin suppresses insulin-like growth factor I receptor signaling in human prostate cancer: an in vitro and in vivo study | Q42001138 |
| | Inhibition of protein-tyrosine kinase activity by flavanoids and related compounds | Q43804196 |
| | A painful peripheral neuropathy in the rat produced by the chemotherapeutic drug, paclitaxel | Q43814061 |
| | Enhanced oral bioavailability of paclitaxel by coadministration of the P-glycoprotein inhibitor KR30031. | Q44330532 |
| | Quantitation of paclitaxel in micro-sample rat plasma by a sensitive reversed-phase HPLC assay | Q44332558 |
| | Influence of quercetin on the pharmacokinetics of ranolazine in rats and in vitro models | Q44451449 |
| | Enhanced bioavailability of paclitaxel after oral coadministration with flavone in rats | Q44841876 |
| | The effect of verapamil on the pharmacokinetics of paclitaxel in rats | Q45207270 |
| | Enhanced paclitaxel bioavailability after oral coadministration of paclitaxel prodrug with naringin to rats | Q45278500 |
| | Apigenin protects endothelium-dependent relaxation of rat aorta against oxidative stress. | Q45956534 |
| | Effects of quercetin on the pharmacokinetics of Etoposide after oral or intravenous administration of etoposide in rats. | Q46026038 |
| | Pharmacokinetic interaction study between quercetin and valsartan in rats and in vitro models | Q46063158 |
| | Pharmacokinetic and pharmacodynamic interactions of morin and cyclosporin | Q46483175 |
| | Effects of oral kaempferol on the pharmacokinetics of tamoxifen and one of its metabolites, 4-hydroxytamoxifen, after oral administration of tamoxifen to rats | Q46704237 |
| | Role of p-glycoprotein inhibition for drug interactions: evidence from in vitro and pharmacoepidemiological studies | Q46890019 |
| | Rutin improves the antioxidant status in streptozotocin-induced diabetic rat tissues | Q48492620 |
| | Enhanced paclitaxel bioavailability after oral administration of pegylated paclitaxel prodrug for oral delivery in rats. | Q51643335 |
| | Evidence for protective and antioxidant properties of rutin, a natural flavone, against ethanol induced gastric lesions | Q62950307 |
| | Effect of R-verapamil on the pharmacokinetics of paclitaxel in women with breast cancer | Q71961929 |
| | Specific CYP3A4 inhibitors in grapefruit juice: furocoumarin dimers as components of drug interaction | Q73834871 |
| P433 | issue | 3 | |
| P921 | main subject | pharmacokinetics | Q323936 |
| | paclitaxel | Q423762 |
| P304 | page(s) | 267-276 | |
| P577 | publication date | 2014-05-29 | |
| P1433 | published in | European Journal of Drug Metabolism and Pharmacokinetics | Q15757261 |
| P1476 | title | Pharmacokinetic drug interactions between apigenin, rutin and paclitaxel mediated by P-glycoprotein in rats | |
| P478 | volume | 40 | |